TGFB1 and Hepatic fibrosis: Furthermore, the reduction of liver fibrosis was confirmed in mice receiving PD‐MC by quantitatively analyzing hydroxyproline and fibrotic markers such as, Col1α1, TGF‐β, and TIMP‐1 (Figure 8C,D).